irsogladine has been researched along with Mucositis, Oral in 4 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Excerpt | Relevance | Reference |
---|---|---|
" The incidence and maximum severity of fluorouracil-induced oral mucositis and safety of the irsogladine dosing regimen were evaluated." | 2.78 | Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis. ( Hayashi, K; Kamata, M; Kojima, H; Nomura, M; Sawada, S, 2013) |
"Alimentary mucositis is a significant complication of cancer therapy, with important clinical and economic implications." | 2.43 | Anti-inflammatory agents in the management of alimentary mucositis. ( Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM, 2006) |
"Irsogladine maleate (IM) is a drug with gastric mucosal protective properties." | 1.48 | [Development of "Patient Friendly Formulations" to Counter the Side Effects of Cancer Chemotherapy]. ( Hanawa, T; Kawano, Y; Satoh, M, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanawa, T | 2 |
Kawano, Y | 2 |
Satoh, M | 2 |
Imamura, A | 1 |
Nakamura, T | 1 |
Akaishi, M | 1 |
Nomura, M | 1 |
Kamata, M | 1 |
Kojima, H | 1 |
Hayashi, K | 1 |
Sawada, S | 1 |
Lalla, RV | 1 |
Schubert, MM | 1 |
Bensadoun, RJ | 1 |
Keefe, D | 1 |
1 review available for irsogladine and Mucositis, Oral
Article | Year |
---|---|
Anti-inflammatory agents in the management of alimentary mucositis.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antineoplastic Agents; Benzydamin | 2006 |
1 trial available for irsogladine and Mucositis, Oral
Article | Year |
---|---|
Irsogladine maleate reduces the incidence of fluorouracil-based chemotherapy-induced oral mucositis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Drug-Related Side | 2013 |
2 other studies available for irsogladine and Mucositis, Oral
Article | Year |
---|---|
[Development of "Patient Friendly Formulations" to Counter the Side Effects of Cancer Chemotherapy].
Topics: Administration, Oral; Alanine; Animals; Antineoplastic Agents; Cell Communication; Cyclic AMP; Disea | 2018 |
Development and Characterization of Oral Spray for Stomatitis Containing Irsogladine Maleate.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Male; Mesocricetus; Oral Sprays; Stomatitis; | 2016 |